Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SYCREST 5 MG COMPRIMIDOS SUBLINGUALES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SYCREST 5 MG COMPRIMIDOS SUBLINGUALES

Approved

STANDARD

SYCREST 5 MG COMPRIMIDOS SUBLINGUALES

Organon N.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 22, 2023
Approval ID: 5408f5de1917be88
Company: Organon N.V.
Type: Standard

Approval Details

Approval Id: 5408f5de1917be88
Drug Cima Aemps Name: SYCREST 5 MG COMPRIMIDOS SUBLINGUALES
Register Number: 10640002IP2
Holder Company Name: Organon N.V.
Marketing Company Name: Ecofar Productos S.L.
Authorization Date: 2023-02-22
Dosage Form: COMPRIMIDO SUBLINGUAL
Dose: 5 mg
Route Of Administration: VÍA SUBLINGUAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Organon N.V.

Active Ingredients

ASENAPINA MALEATO

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 22, 2023

Approval ID

5408f5de1917be88

Type

Standard

Back to CIMA-AEMPS Approvals